Shanghai Serum Bio-Technology Co., Ltd. (SHA:688163)

SHA:688163 Revenue

Shanghai Serum Bio-Technology had revenue of 75.20M CNY in the quarter ending June 30, 2025, with 4.80% growth. This brings the company's revenue in the last twelve months to 197.68M, up 1.66% year-over-year. In the year 2024, Shanghai Serum Bio-Technology had annual revenue of 194.92M with 2.51% growth.

• Revenue (ttm): 197.68M
• Revenue Growth: +1.66%
• P/S Ratio: 12.61
• Revenue / Employee: 610.11K
• Employees: 326
• Market Cap: 2.49B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	194.92M	4.77M	2.51%
Dec 31, 2023	190.14M	15.92M	9.14%
Dec 31, 2022	174.22M	-34.47M	-16.52%
Dec 31, 2021	208.69M	23.13M	12.47%
Dec 31, 2020	185.56M	-2.53M	-1.35%